CRA Insights

The value of marketing alliances between pharmaceutical companies

July 8, 2009

Alliances between pharmaceutical companies can take a number of forms to accommodate the strategic interests of the partnering firms. These alliances also occur at different stages in the product lifecycle, from early stage product development, to late stage development to the sales and marketing of an approved product, and even occur once a product is approaching or reaches patent expiry. CRA’s Life Sciences Practice has been asked to assess the value of different types of marketing alliances.

Key contacts